Helgi Jung

968 total citations
25 papers, 716 citations indexed

About

Helgi Jung is a scholar working on Pathology and Forensic Medicine, Parasitology and Ecology. According to data from OpenAlex, Helgi Jung has authored 25 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 10 papers in Parasitology and 7 papers in Ecology. Recurrent topics in Helgi Jung's work include Parasitic infections in humans and animals (13 papers), Parasites and Host Interactions (10 papers) and Parasite Biology and Host Interactions (7 papers). Helgi Jung is often cited by papers focused on Parasitic infections in humans and animals (13 papers), Parasites and Host Interactions (10 papers) and Parasite Biology and Host Interactions (7 papers). Helgi Jung collaborates with scholars based in Mexico, Spain and Portugal. Helgi Jung's co-authors include Julio Sotelo, Marco T. Medina, Marcela Hurtado, Nelly Castro, Agnès Fleury, Dinora F. González‐Esquivel, Graciela Cárdenas, Edda Sciutto, Roger Carrillo‐Mezo and José Luis Soto‐Hernández and has published in prestigious journals such as Neurology, Antimicrobial Agents and Chemotherapy and Phytochemistry.

In The Last Decade

Helgi Jung

25 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helgi Jung Mexico 16 303 257 192 151 108 25 716
H. W. Diekmann Germany 13 174 0.6× 238 0.9× 127 0.7× 63 0.4× 136 1.3× 21 596
Helgi Jung Mexico 7 89 0.3× 104 0.4× 65 0.3× 45 0.3× 61 0.6× 14 314
Shu-Hua Xiao China 18 70 0.2× 784 3.1× 528 2.8× 34 0.2× 351 3.3× 70 1.2k
Kitti Intuyod Thailand 15 37 0.1× 128 0.5× 69 0.4× 91 0.6× 52 0.5× 49 531
S. M. A. Abidi India 16 56 0.2× 209 0.8× 170 0.9× 41 0.3× 204 1.9× 58 693
L. García Mexico 6 22 0.1× 43 0.2× 34 0.2× 17 0.1× 40 0.4× 12 394
S. K. Chowdhury Canada 6 16 0.1× 141 0.5× 38 0.2× 21 0.1× 40 0.4× 7 454
Abdel‐Hamid Z. Abdel‐Hamid Egypt 15 20 0.1× 56 0.2× 68 0.4× 12 0.1× 33 0.3× 26 477
B. Kaye United Kingdom 13 27 0.1× 73 0.3× 46 0.2× 4 0.0× 197 1.8× 27 635
Aparajita Chatterjee United States 14 25 0.1× 88 0.3× 10 0.1× 29 0.2× 10 0.1× 22 539

Countries citing papers authored by Helgi Jung

Since Specialization
Citations

This map shows the geographic impact of Helgi Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helgi Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helgi Jung more than expected).

Fields of papers citing papers by Helgi Jung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helgi Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helgi Jung. The network helps show where Helgi Jung may publish in the future.

Co-authorship network of co-authors of Helgi Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Helgi Jung. A scholar is included among the top collaborators of Helgi Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helgi Jung. Helgi Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carrillo‐Mezo, Roger, et al.. (2018). Factors Associated With Cysticidal Treatment Response in Extraparenchymal Neurocysticercosis. The Journal of Clinical Pharmacology. 59(4). 548–556. 24 indexed citations
2.
Cárdenas, Graciela, Roger Carrillo‐Mezo, Helgi Jung, et al.. (2010). Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series. BMC Neurology. 10(1). 16–16. 43 indexed citations
3.
Cárdenas, Graciela, Helgi Jung, Camilo Rı́os, Agnès Fleury, & José Luis Soto‐Hernández. (2010). Severe Cysticercal Meningitis: Clinical and Imaging Characteristics. American Journal of Tropical Medicine and Hygiene. 82(1). 121–125. 14 indexed citations
4.
Castro, Nelly, et al.. (2009). Population pharmacokinetics of albendazole in patients with neurocysticercosis.. PubMed. 47(11). 679–85. 18 indexed citations
5.
Fleury, Agnès, Helgi Jung, Graciela Cárdenas, & Edda Sciutto. (2008). Medical Treatment for Neurocysticercosis: Drugs, Indications and Perspectives. Current Topics in Medicinal Chemistry. 8(5). 424–433. 22 indexed citations
6.
Castro, Nelly, et al.. (2002). Interaction between Grapefruit Juice and Praziquantel in Humans. Antimicrobial Agents and Chemotherapy. 46(5). 1614–1616. 38 indexed citations
7.
Castro, Nelly, et al.. (2000). Bioavailability of Praziquantel Increases with Concomitant Administration of Food. Antimicrobial Agents and Chemotherapy. 44(10). 2903–2904. 80 indexed citations
8.
Sotelo, Julio & Helgi Jung. (1998). Pharmacokinetic Optimisation of the Treatment of Neurocysticercosis. Clinical Pharmacokinetics. 34(6). 503–515. 61 indexed citations
9.
García, L., et al.. (1998). Pharmacokinetic Interaction in Rabbits between a New Anticonvulsant, DL-3-Hydroxy-3-ethyl-3-phenylpropionamide, and Phenytoin. Journal of Pharmacy and Pharmacology. 50(12). 1393–1396. 5 indexed citations
10.
Jung, Helgi, et al.. (1997). CLINICAL PHARMACOKINETICS OF ALBENDAZOLE IN CHILDREN WITH NEUROCYSTICERCOSIS. American Journal of Therapeutics. 4(1). 23–26. 15 indexed citations
11.
Jung, Helgi, et al.. (1997). THE INFLUENCE OF COFFEE WITH MILK AND TEA WITH MILK ON THE BIOAVAILABILITY OF TETRACYCLINE. Biopharmaceutics & Drug Disposition. 18(5). 459–463. 33 indexed citations
12.
Castro, Nelly, et al.. (1997). The influence of cimetidine on plasma levels of praziquantel after a single day therapeutic regimen.. PubMed. 40. 33–4. 2 indexed citations
13.
Jung, Helgi, et al.. (1993). Bioequivalence study of nalidixic acid tablets: In vitro–in vivo correlation. Biopharmaceutics & Drug Disposition. 14(5). 381–388. 3 indexed citations
14.
González‐Esquivel, Dinora F., et al.. (1993). Pharmacokinetic Comparison of Two Albendazole Dosage Regimens in Patients with Neurocysticercosis. Clinical Neuropharmacology. 16(1). 77–82. 19 indexed citations
15.
Jung, Helgi, et al.. (1992). Clinical Pharmacokinetics of Albendazole in Patients with Brain Cysticercosis. The Journal of Clinical Pharmacology. 32(1). 28–31. 42 indexed citations
16.
Jung, Helgi, et al.. (1991). Clinical pharmacokinetics of praziquantel.. PubMed. 34. 335–40. 8 indexed citations
17.
Jung, Helgi, et al.. (1990). Plasma and CSF Levels of Albendazole and Praziquantel in Patients with Neurocysticercosis. Clinical Neuropharmacology. 13(6). 559–564. 64 indexed citations
18.
Jung, Helgi, et al.. (1990). Dexamethasone increases plasma levels of albendazole. Journal of Neurology. 237(5). 279–280. 89 indexed citations
19.
Hurtado, Marcela, Marco T. Medina, Julio Sotelo, & Helgi Jung. (1989). Sensitive high-performance liquid chromatographic assay for albendazole and its main metabolite albendazole sulphoxide in plasma and cerebrospinal fluid. Journal of Chromatography B Biomedical Sciences and Applications. 494. 403–407. 36 indexed citations
20.
Yáñez, Leticia, et al.. (1988). Norethisterone-cholesterol eutectic mixture as an oral sustained-release hormonal preparation: Bioequivalence study in humans. Contraception. 37(4). 349–357. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. W. Diekmann Breakdown of academic impact, for papers by Helgi Jung Breakdown of academic impact, for papers by Shu-Hua Xiao Breakdown of academic impact, for papers by Kitti Intuyod Breakdown of academic impact, for papers by S. M. A. Abidi Breakdown of academic impact, for papers by L. García Breakdown of academic impact, for papers by S. K. Chowdhury Breakdown of academic impact, for papers by Abdel‐Hamid Z. Abdel‐Hamid Breakdown of academic impact, for papers by B. Kaye Breakdown of academic impact, for papers by Aparajita Chatterjee
Rankless by CCL
2026